Search research articles
Contact Us
Filters
Showing results (11-20 of 69) with videos related to
Page
of 7
Sort By:
Maturitas
|
June 8, 2001
Perspectives in hormone replacement therapy
P Kenemans, G A van Unnik, V Mijatovic, et al.
Facts, Views & Vision in Obgyn
|
November 8, 2019
Treatment of ovarian endometriomas using plasma energy in endometriosis surgery: effect on pelvic pain, return to work, pregnancy and cyst recurrence
E K Lockyer, Amf Schreurs, McI Lier, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
August 19, 1999
L-thyroxine prevents the bone-conserving effect of HRT in postmenopausal women with subclinical hypothyroidism
A Pines, I Dotan, U Tabori, et al.
Journal of Internal Medicine
|
December 3, 1999
The effect of various hormonal preparations and calcium supplementation on bone mass in early menopause. Is there a predictive value for the initial bone density and body weight?
A Pines, H Katchman, Y Villa, et al.
Maturitas
|
November 20, 1998
Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease
M J van der Mooren, V Mijatovic, W M van Baal, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
July 10, 1999
Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection
V Mijatovic, M J van der Mooren, C D Stehouwer, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 5, 2005
HMR 3339, a novel selective estrogen receptor modulator, reduces concentrations of procarboxypeptidase U, an inhibitor of fibrinolysis. A randomized, placebo-controlled study in postmenopausal women
T E Vogelvang, J R Leurs, V Mijatovic, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
October 17, 2009
Irritable bowel syndrome and chronic constipation in patients with endometriosis
M M Meurs-Szojda, V Mijatovic, R J F Felt-Bersma, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
November 18, 2016
High miscarriage rate in women treated with Essure® for hydrosalpinx before embryo transfer: a systematic review and meta-analysis
M W Barbosa, A Sotiriadis, S I Papatheodorou, et al.
Anticancer Research
|
March 4, 2000
Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study
E M Schutter, V Mijatovic, A Kok, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 69) with videos related to
Sort By:
Page
of 7
Maturitas
|
June 8, 2001
Perspectives in hormone replacement therapy
P Kenemans, G A van Unnik, V Mijatovic, et al.
Facts, Views & Vision in Obgyn
|
November 8, 2019
Treatment of ovarian endometriomas using plasma energy in endometriosis surgery: effect on pelvic pain, return to work, pregnancy and cyst recurrence
E K Lockyer, Amf Schreurs, McI Lier, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
August 19, 1999
L-thyroxine prevents the bone-conserving effect of HRT in postmenopausal women with subclinical hypothyroidism
A Pines, I Dotan, U Tabori, et al.
Journal of Internal Medicine
|
December 3, 1999
The effect of various hormonal preparations and calcium supplementation on bone mass in early menopause. Is there a predictive value for the initial bone density and body weight?
A Pines, H Katchman, Y Villa, et al.
Maturitas
|
November 20, 1998
Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease
M J van der Mooren, V Mijatovic, W M van Baal, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
July 10, 1999
Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection
V Mijatovic, M J van der Mooren, C D Stehouwer, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 5, 2005
HMR 3339, a novel selective estrogen receptor modulator, reduces concentrations of procarboxypeptidase U, an inhibitor of fibrinolysis. A randomized, placebo-controlled study in postmenopausal women
T E Vogelvang, J R Leurs, V Mijatovic, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
October 17, 2009
Irritable bowel syndrome and chronic constipation in patients with endometriosis
M M Meurs-Szojda, V Mijatovic, R J F Felt-Bersma, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
November 18, 2016
High miscarriage rate in women treated with Essure® for hydrosalpinx before embryo transfer: a systematic review and meta-analysis
M W Barbosa, A Sotiriadis, S I Papatheodorou, et al.
Anticancer Research
|
March 4, 2000
Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study
E M Schutter, V Mijatovic, A Kok, et al.
Page
of 7